Magenta Therapeutics

-$0.16 (-2.16%) Today

$0.00 (0.00%) As of 12:55 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGTA and other ETFs, options, and stocks.

About MGTA

Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers patient preparation, stem cell collection, cell dose, and safe immune regeneration programs.

CEO

Jason Gardner

Employees

Headquarters

Cambridge, Massachusetts

Founded

2015

MGTA Key Statistics

Market Cap

560.25M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

248.04K

High Today

$7.60

Low Today

$6.95

Open Price

$7.60

Volume

303.94K

52 Week High

$14.20

52 Week Low

$6.03

Analyst Ratings

100%

of 8 ratings

Buy

100%

Hold

Sell

MGTA Earnings

-$0.59

-$0.39

-$0.20

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 5, Pre-Market